Mark Maloney received his Ph.D. from the University of Massachusetts at Amherst in 1988. He then completed a postdoctoral fellowship in Microbiology at the Hospital for Sick Children in Toronto, Ontario. He currently serves as Professor and Vice Chair of Biology at Spelman College having joined the Biology Department in 1994.

His research interests include the role of globotriaosyl ceramide (Gb3 or CD77) as Shiga toxin receptor and the roles of glycolipid-protein interaction in functions of germinal center stage B cells and Burkitt’s lymphoma cells.

Peter George Traber is an American pharmaceutical company executive. He is President and Chief Executive Officer for Galectin Therapeutics.

Gastroenterology, Medicine, Galectin Therapeutics.

He holds the MTA-PE Lendulet professorship in Translational Glycomics and directs the Horváth Csaba Laboratory of Bioseparation Sciences in University of Pannonia (Hungary). His work is focused on capillary electrophoresis and CESI-MS based glycomics and glycoproteomics analysis of biomedical, cell biology and biopharmaceutical, interests. Professor Guttman has more than 290 scientific publications, wrote 35 book chapters, edited 4 textbooks and holds 23 patents. He is on the board of several international organizations, on the editorial boards of a dozen scientific journals, has been recognized by numerous awards and member of the Hungarian Academy of Sciences.

His research interests include the glycomics and glycoproteomics analysis of biomedical, cell biology and biopharmaceutical.

Jack angel elias is the Dean of Medicine and Biologic Sciences and Professor of Molecular Biology, Cell Biology and Biochemistry from the Division of Biology and Medicine in the Brown University. He then completed his education from University of Pennsylvania in 1976 He currently serves as Professor of Medicine, Warren Alpert School of Medicine, Brown University in 2014.

His research interest includes Biochemistry, Cell Biology, Molecular Microbiology, Biologic Sciences and Critical Care Medicine.

Yaoqi Zhou received his BS in Chemical Physics from University of Science and Technology of China and PhD in Chemical Physics from State University of New York at Stony Brook, USA in 1990. He conducted his postdoctoral studies at North-Carolina State University and Harvard University. He was an Assistant Professor and later Associate Professor at Department of Physiology and Biophysics, State University of New York at Buffalo, USA, from 2000 to 2006, and a full Professor at Schools of Informatics and Medicine, Indiana University, USA, from 2006 to 2013. He joined the Institute for Glycomics at Griffith University as a Professor of Computational Biology in 2013. His group has developed more than 10 popular bioinformatics tools including prediction of glycan-binding proteins.

His research interest includes development of computational algorithms and bioinformatics techniques that predict structural and functional properties of proteins and RNAs, discriminate disease-causing from neutral genetic variations, and design small molecule and peptide inhibitors for antibiotic, antiviral and anti-cancer therapeutics.